# Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients

> **NCT07568886** · NA · COMPLETED · sponsor: **Al-Nahrain University** · enrollment: 200 (actual)

## Conditions studied

- Ovarian Hyper Stimulation Syndrome (OHSS)

## Interventions

- **DRUG:** Albumin (Human) 20%
- **DRUG:** Furosemide
- **DRUG:** Standard luteal phase support

## Key facts

- **NCT ID:** NCT07568886
- **Lead sponsor:** Al-Nahrain University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-29
- **Primary completion:** 2023-04-27
- **Final completion:** 2024-04-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07568886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07568886, "Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07568886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*